HeraMED Receives FDA 510(k) Clearance for HeraBEAT Device
Filed with ASX · · 2 pages · English
Earlier from HeraMED
- Retraction of Statements - Next Tech Stock Article
- Pause in Trade
- Response to ASX Price and Volume Query
- September Quarter Activities Report and Appendix 4C
- Market entry for HeraBEAT and HeraCARE Progresses in India
Later from HeraMED
- Agreement adds telehealth services to Herabeat in Germany
- Indian Hospital Group Cooperates with H-Cube and HeraMED
- A$1.42m strategic placement completed to expedite US entry
- Response to ASX Aware Query
- HMD accesses unique pregnancy database to strengthen OrionAI
Follow HeraMED into a list and get an email when it puts out news.
Follow HeraMED